MacroGenics has revealed the data presentation from Phase 2 of the TAMARACK study at the ESMO Congress in 2024.

MacroGenics to host investor call to review key data presented at ESMO on Monday, September 16, 2024, at 8:00 a.m. ETROCKVILLE, MD, Sept. 08, 2024 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ…

Read More: https://www.globenewswire.com/news-release/2024/09/08/2942475/0/en/MacroGenics-Announces-TAMARACK-Phase-2-Data-Presentation-at-ESMO-Congress-2024.html